Aside from c-myc, mitochondrial matrix chaperones are also known to control tumor cell metabolism [8] and the specific interference with these molecules by a small molecule, called Gamitrinib [9, 10], represents a viable therapeutic opportunity. Here, MYC is linked to neoplasm.